Glabratephrin reverses doxorubicin resistance in triple negative breast cancer by inhibiting P-glycoprotein

Citation:
Abd-ellatefa, G. E. F., E. Gazzano, A. H. El-Desoky, A. R. Hamed, J. Kopecka, D. C. Belisario, C. Costamagna, M. A. S. Marie, S. R. Fahmy, A. - H. Z. Abdel-Hamid, et al., "Glabratephrin reverses doxorubicin resistance in triple negative breast cancer by inhibiting P-glycoprotein", Pharmacological Research, vol. 175, issue 2022, pp. 105975, 2022.
Tourism